Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Danaher Corporation    DHR

Delayed Quote. Delayed  - 12/08 08:48:35 pm
77.91 USD   +1.22%
12/06 DANAHER : Announces Quarterly Dividend
12/01 DANAHER : announces leadership appointment
11/23 Global E. Coli Testing Market - Abbott Laboratories, Danaher Corp..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

X-Rite Agrees To Be Acquired By Danaher In $478 Million Deal

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/10/2012 | 02:45pm CET

Color-measurement technology company X-Rite Inc. (XRIT) agreed to be acquired by diversified manufacturer Danaher Corp. (>> Danaher Corporation) in a deal valued at $478 million.

The $5.55-a-share offer represents a 39% premium to Monday's closing price. X-Rite shares closed Monday at $4 each and were halted in recent premarket trading. The stock is down 14% this year.

X-Rite Chief Executive Thomas J. Vacchiano Jr. said that joining Danaher will give the company--known for Pantone color matching system--resources to achieve its growth goals, expanded access to new market and complementary technologies.

After the deal closes, anticipated in the current quarter, X-Rite will operate as a standalone unit in Danaher's product identification group and existing management will remain in senior leadership positions.

Danaher expects the acquisition will complement its Esko digital packaging design capabilities and further its leading position in the product identification industry. The diversified toolmaker has been relying on acquisitions to bolster a slow-growing revenue base.

Including debt assumption and net of cash, the deal is valued at a total of $625 million.

Danaher shares closed Monday at $54.59 and were inactive in recent premarket trading.

-By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com

Stocks mentioned in the article : Danaher Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DANAHER CORPORATION
12/06 DANAHER CORP /DE/ : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Y..
12/06 DANAHER : Announces Quarterly Dividend
12/01 DANAHER : announces leadership appointment
11/23 Global E. Coli Testing Market - Abbott Laboratories, Danaher Corporation, Bio..
11/16 DANAHER : Meritage Portfolio Management buys $7,220,284 stake in Danaher Corpora..
11/14 DANAHER : To Webcast Investor And Analyst Meeting
11/10 DANAHER CORP /DE/ : Other Events (form 8-K)
11/09 DANAHER : Van Hulzen Asset Management buys $2,893,901 stake in Danaher Corporati..
10/31 DANAHER : to Present at Baird Industrial Conference
10/27 DANAHER : Reports Third Quarter 2016 Results
More news
Sector news : Advanced Medical Equipment & Technology - NEC
06:35p AIXTRON : China's Fujian drops Aixtron bid after Obama blocks deal
12/05 Aixtron could revive takeover despite U.S. block
12/02 Deals scuppered by U.S. regulatory scrutiny
11/29 European spin-offs and carve-outs
11/15 EXCLUSIVE : EU regulators seen clearing $25 billion Abbott, St Jude deal
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
12/06 Danaher Corporation declares $0.125 dividend
12/04 NOVEMBER : My Fund Trumped As Interest Rates, Dollar Weigh Heavily
11/30 A Guide To Investing In Water
11/30 Fortive Could Be A New Industrial Star
11/30 Tracking Ruane, Cunniff & Goldfarb's Portfolio - Q3 2016 Update
Advertisement
Financials ($)
Sales 2016 16 824 M
EBIT 2016 2 959 M
Net income 2016 2 318 M
Debt 2016 7 532 M
Yield 2016 0,75%
P/E ratio 2016 23,23
P/E ratio 2017 22,74
EV / Sales 2016 3,61x
EV / Sales 2017 3,25x
Capitalization 53 240 M
More Financials
Chart DANAHER CORPORATION
Duration : Period :
Danaher Corporation Technical Analysis Chart | DHR | US2358511028 | 4-Traders
Full-screen chart
Technical analysis trends DANAHER CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 89,3 $
Spread / Average Target 16%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Thomas Patrick Joyce President, Chief Executive Officer & Director
Stephen M. Rales Chairman
Daniel L. Comas Chief Financial Officer & Executive Vice President
Alan G. Spoon Independent Director
Donald Jerry Ehrlich Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
DANAHER CORPORATION7.92%53 240
THERMO FISHER SCIENTIF..0.00%56 034
PHILIPS15.41%28 279
BOSTON SCIENTIFIC CORP..11.77%28 064
INTUITIVE SURGICAL, IN..13.81%23 985
ILLUMINA, INC.-34.15%17 925
More Results